[Therapy of chronic myelogenous leukemia].
Shibata
A
A
Hashimoto
S
S
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D010677:Philadelphia Chromosome
D000477:Alkylating Agents; D007372:Interferons; D015122:Mercaptopurine; D006918:Hydroxyurea